Literature DB >> 8168670

Prescription of antibiotics and prescribers' characteristics. A study into prescription of antibiotics in upper respiratory tract infections in general practice.

M Kuyvenhoven1, R de Melker, K van der Velden.   

Abstract

There is a growing concern about rational prescribing of antibiotics. That is why a secondary analysis of prescribing antibiotics in upper respiratory tract infections has been conducted by means of a nationwide study of morbidity and interventions in The Netherlands. The mean percentage of antibiotic prescriptions varied from about 20% for acute otitis media and acute upper respiratory tract infections to about 70% for sinusitis and tonsillitis. Only attitude--toward prescribing antibiotics in sore throat--and years of settlement were important predictor variables. The other characteristics studied--type of practice, list size, frequency of use of Het Farmacotherapeutisch Kompas, containing national pharmacotherapeutical guidelines, and urbanization level were not. The importance of attitude, however, was less for general practitioners who went into practice after 1975. This means that the influence of a personal characteristic as attitude might have become less influential since the introduction of vocational training for general practice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8168670     DOI: 10.1093/fampra/10.4.366

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  14 in total

1.  GPs' antibiotic prescription patterns for respiratory tract infections--still room for improvement.

Authors:  Svein Gjelstad; Ingvild Dalen; Morten Lindbaek
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581

2.  Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults.

Authors:  T Fahey; N Stocks; T Thomas
Journal:  BMJ       Date:  1998-03-21

3.  The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial.

Authors:  W Stalman; G A van Essen; Y van der Graaf; R A de Melker
Journal:  Br J Gen Pract       Date:  1997-12       Impact factor: 5.386

4.  Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics.

Authors:  Annemiek E Akkerman; Marijke M Kuyvenhoven; Johannes C van der Wouden; Theo J M Verheij
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

5.  A qualitative comparative investigation of variation in general practitioners' prescribing patterns.

Authors:  Chrys Jaye; Murray Tilyard
Journal:  Br J Gen Pract       Date:  2002-05       Impact factor: 5.386

6.  Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats.

Authors:  C C Butler; S Rollnick; R Pill; F Maggs-Rapport; N Stott
Journal:  BMJ       Date:  1998-09-05

7.  Characteristics of children consulting for cough, sore throat, or earache.

Authors:  Johannes H J M Uijen; Huug J van Duijn; Marijke M Kuyvenhoven; François G Schellevis; Johannes C van der Wouden
Journal:  Br J Gen Pract       Date:  2008-04       Impact factor: 5.386

8.  Which practices are high antibiotic prescribers? A cross-sectional analysis.

Authors:  Kay Yee Wang; Paul Seed; Peter Schofield; Saima Ibrahim; Mark Ashworth
Journal:  Br J Gen Pract       Date:  2009-10       Impact factor: 5.386

9.  Factors affecting the prescribing patterns of antibiotics and injections.

Authors:  Kyung-Hyun Choi; Sang-Min Park; Ju-Hyun Lee; Soonman Kwon
Journal:  J Korean Med Sci       Date:  2012-01-27       Impact factor: 2.153

10.  Diagnostic labelling as determinant of antibiotic prescribing for acute respiratory tract episodes in general practice.

Authors:  Huug J van Duijn; Marijke M Kuyvenhoven; Hanneke M Tiebosch; François G Schellevis; Theo J M Verheij
Journal:  BMC Fam Pract       Date:  2007-09-20       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.